本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aclaris Therapeutics

1.61
+0.02001.26%
盤後1.610.00000.00%19:44 EDT
成交量:65.04萬
成交額:104.66萬
市值:1.74億
市盈率:-1.11
高:1.63
開:1.61
低:1.58
收:1.59
資料載入中...
2022/01/14

重要事件披露

8-K - Current report
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/02

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/26

重要事件披露

8-K - Current report
2021/06/11

重要事件披露

8-K - Current report
2021/06/08

重要事件披露

8-K - Current report
2021/06/03

重要事件披露

8-K - Current report
2021/05/20

重要事件披露

8-K - Current report
2021/05/07

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/07

重要事件披露

8-K - Current report
2021/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals